Navigation Links
Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan
Date:7/14/2014

subject to numerous assumptions, risks and uncertainties that change over time and could cause actual results to differ materially from those described in the forward-looking statements.  These assumptions, risks and uncertainties include, but are not limited to, assumptions, risks and uncertainties discussed in the company's most recent annual or quarterly report filed with the SEC and the Canadian Securities Administrators (the "CSA") and assumptions, risks and uncertainties relating to the proposed merger, as detailed from time to time in Valeant's filings with the SEC and the CSA, which factors are incorporated herein by reference.  Important factors that could cause actual results to differ materially from the forward-looking statements we make in this communication are set forth in other reports or documents that we file from time to time with the SEC and the CSA, and include, but are not limited to:

  • the ultimate outcome of the offer and the second-step merger, including the ultimate removal or the failure to render inapplicable the obstacles to consummation of the offer and the second-step merger described in the offer to exchange;
  • the ultimate outcome and results of integrating the operations of Valeant and Allergan, the ultimate outcome of Valeant's pricing and operating strategy applied to Allergan and the ultimate ability to realize synergies;
  • the effects of the proposed combination of Valeant and Allergan, including the combined company's future financial condition, operating results, strategy and plans;
  • the effects of governmental regulation on our business or potential business combination transactions;
  • the ability to obtain regulatory approvals and meet other conditions to the offer, including the necessary stockholder approval, on a timely basis;
  • Valeant's ability to sustain and grow revenues and cash flow from operations in our markets
    '/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma
2. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
3. Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan
4. Valeant Pharmaceuticals To Present At Industry Conferences
5. Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
6. Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
7. Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes
8. Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
9. Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
10. Valeant Pharmaceuticals Announces Settlement Agreement With Anacor
11. Valeant Pharmaceuticals Announces Partnership With National Coalition Against Domestic Violence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... --  iRhythm Technologies, Inc. , a leading digital healthcare solutions ... today that Banner Health, one of the largest nonprofit ... offering iRhythm,s ZIO ® Service to patients in ... Banner Health, we are dedicated to strengthening our patient ... John Hensing , MD, Banner Health,s executive vice president ...
(Date:4/21/2015)... 21, 2015  Decision Diagnostics Corp. (OTC PINK: ... exclusive worldwide sales, service and regulatory processes agent ... Alternative Strip, specifically designed to work with the ... family of glucose testing meters, the most popular ... Johnson & Johnson/Lifescan has requested an unscheduled Case ...
(Date:4/21/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today that 2015 first quarter financial results ... that day, the Company will hold a teleconference call ... discuss the results, followed by a question and answer ... and Chief Executive Officer of CryoLife, Inc. ...
Breaking Medicine Technology:Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 2Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 3Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 2Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 3CryoLife Announces Release Date and Teleconference Call Details for 2015 First Quarter Financial Results 2
... , , , , , ... PARIS and LAUSANNE, Switzerland ... innovation-driven global specialty,pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based ... of,prescription drugs that target unmet medical needs, announce the launch ...
... , THE WOODLANDS, Texas , Feb. 3 ... a biopharmaceutical company focused on discovering and developing breakthrough treatments for ... , Lexicon,s president and chief executive officer, will present at the ... on Monday, February 8, 2010 at 9:30 a.m., ...
Cached Medicine Technology:Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 2Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 3Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 4Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 5Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 6Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference 2Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference 3
(Date:4/21/2015)... (PRWEB) April 21, 2015 “ ZeroWire ... monthly Tech Report, which takes a look at the ... consumers. Scott Steinberg, a special reporter for NewsWatch and ... viewers how ZeroWire is a security system and lifestyle ... Investigation, there were over 2 million burglaries in 2010. ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 The joint ... today it is opening its first freestanding emergency room ... Chandler, Arizona and will be licensed under Dignity Health ... Dignity Health and Adeptus Health joint venture. , Tim ... and Mercy Gilbert Medical Centers said the new facility ...
(Date:4/21/2015)... Wireless Analytics, LLC , a pioneering ... the Boston Business Journal as the 25th fastest-growing private ... a recent event celebrating the 2015 Pacesetters, the ... companies in Massachusetts. , Wireless Analytics was ranked among ... the fastest revenue growth from 2011 through 2014. ...
(Date:4/21/2015)... April 21, 2015 The ... provides comparative analysis on the therapeutic development ... pipelines by identifying new targets and MOAs ... report with TOC is available @ ... reviews key players involved in the therapeutic ...
(Date:4/21/2015)... Riverside, CA (PRWEB) April 21, 2015 ... Programs, and Arthur “A.G.” Kawamura, former Secretary of the ... as featured speakers for the 2nd Annual GrowRIVERSIDE Conference: ... , The inclusion of these nationally known ... agriculture experts, city planners, farmers and others slated to ...
Breaking Medicine News(10 mins):Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 2Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 3
... May 13 The National Business Group on ... from some policymakers that would increase taxes on American ... represents 300 large employers - including 60 of the ... million Americans:"With our nation reeling from the worst economy ...
... Stephen T. Greenberg, a nationally known plastic surgeon, author ... and television personality is hosting a cosmetic surgery fashion ... surgery procedures. He will be speaking about hot topics ... fighter package and cosmetic surgery in a struggling economy.He ...
... to feature Best Hospitals in top categories and behind-the-scene highlights ... U.S. News and HealthiNation , ... video series featuring a selection of hospitals meeting the gold ... News ,s prestigious 2009 America,s Best Hospitals ...
... industry-established standards for all health data processing ... On-Line, a healthcare EDI company that processes ... today it has achieved full accreditation with ... the Electronic Healthcare Network Accreditation Commission (EHNAC). ...
... A potential vaccine for Alzheimer,s disease also has been ... associated with inclusion body myositis, a disorder that affects ... IBM patients with weakness, inflammation or atrophy of muscles ... no cure for IBM, nor is there an effective ...
... customers shop instant online coupons , sales and earn ... dollars(TM) programBELLEVUE, Wash., May 13 drugstore.com , inc. ... health, beauty, vision, and pharmacy products, is experiencing a dramatic ... the number of consumers visiting its coupon, sale and clearance ...
Cached Medicine News:Health News:U.S. News Media Group Announces 'America's Best Hospitals' Video Series 2Health News:U.S. News Media Group Announces 'America's Best Hospitals' Video Series 3Health News:U.S. News Media Group Announces 'America's Best Hospitals' Video Series 4Health News:MD On-Line, Inc. Receives EHNAC Healthcare Network Accreditation 2Health News:MD On-Line, Inc. Receives EHNAC Healthcare Network Accreditation 3Health News:Vaccine slows progression of skeletal muscle disorder 2Health News:Record Number of drugstore.com Customers Search for Bargains 2Health News:Record Number of drugstore.com Customers Search for Bargains 3Health News:Record Number of drugstore.com Customers Search for Bargains 4
The standard of proximal press-fit design. The CLS hip is a straight stem design that is available in 13 sizes in two different neck angles, 135 and 145, to accommodate a wide variety of patient anat...
The Perfecta IMC Stems, manufactured from forged cobalt- chrome, are specifically designed for cemented femoral stem arthroplasty....
Classic proven design with superior clinical results....
The Link SP II Hip stem for cemented revisions...
Medicine Products: